$95.2 Million is the total value of Data Collective IV GP, LLC's 6 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals, Inc. | $45,806,035 | -27.5% | 5,941,120 | 0.0% | 48.11% | -3.7% | |
| Evolv Technologies | $27,457,318 | +22.2% | 10,601,281 | 0.0% | 28.84% | +62.3% | ||
| Rocket Lab USA, Inc. | $11,043,650 | -7.4% | 2,929,350 | 0.0% | 11.60% | +23.1% | ||
| Embark Trucks, Inc. | $10,481,966 | -55.7% | 3,186,008 | 0.0% | 11.01% | -41.2% | ||
| MNMD | Sell | Mind Medicine (MindMed) Inc. | $220,770 | -95.8% | 100,350 | -93.3% | 0.23% | -94.4% |
| New | Roivant Sciences Ltd. | $206,462 | – | 25,840 | +100.0% | 0.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. | 8 | Q3 2023 | 50.0% |
| Evolv Technologies Holdings, Inc. | 8 | Q3 2023 | 47.1% |
| Rocket Lab USA, Inc. | 5 | Q4 2022 | 11.6% |
| Mind Medicine (MindMed) Inc. | 5 | Q4 2022 | 4.1% |
| Embark Trucks, Inc. | 4 | Q2 2023 | 18.7% |
| Roivant Sciences Ltd. | 4 | Q3 2023 | 0.2% |
| Embark Trucks, Inc. | 3 | Q2 2022 | 79.7% |
| Rocket Lab USA, Inc. | 3 | Q3 2023 | 13.0% |
| Mind Medicine (MindMed) Inc. | 3 | Q3 2023 | 0.3% |
View Data Collective IV GP, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR/A | 2022-11-14 |
| 4 | 2022-09-01 |
View Data Collective IV GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.